________________________________________________________________________________________________________________________
Investing for the future
How Veranova is expanding its portfolio and preparing to meet increased demand
Veranova is a global leader in the development and manufacture of specialist and complex active pharmaceutical ingredients ( APIs ) for pharma and biotech customers . The business boasts over 200 active Drug Master Files ( DMFs ) and with expertise in highly regulated and complex chemistry , it focuses on these specialist niches .
With research and development capabilities , Veranova can support various innovations , handling the process from discovery and clinical trials to small or large-scale manufacturing . It also helps with reformulation , supporting other businesses to optimize manufacturing processes and scale-up services with confidence , speed , and flexibility .
David Payne , Vice President and General Manager of Veranova ’ s sites in Scotland , joins us to discuss the company ’ s extensive research , development , and manufacturing facilities across the globe . “ Here at Veranova , we have over 50 years of experience navigating the challenges of the global healthcare industry , as well as nurturing trusted , long-standing customer relationships ,” he begins .
“ We operate within two divisions – generics and originators – which offer a differentiated service tailored to both pharma and biotech customers for every stage in the drug development lifecycle . We boast excellent capabilities across both process and analytical development , as well as process scale-up , technology transfer , and commercial manufacturing .”
172